Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients—A Controlled Clinical Trial

Background: This controlled clinical study aimed to investigate the impact of obesity on plasma and tissue pharmacokinetics of meropenem. Methods: Obese (body mass index (BMI) ≥ 35 kg/m(2)) and age-/sex-matched nonobese (18.5 kg/m(2) ≥ BMI ≤ 30 kg/m(2)) surgical patients received a short-term infusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Philipp, Petroff, David, Busse, David, Heyne, Jana, Girrbach, Felix, Dietrich, Arne, Kratzer, Alexander, Zeitlinger, Markus, Kloft, Charlotte, Kees, Frieder, Wrigge, Hermann, Dorn, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767385/
https://www.ncbi.nlm.nih.gov/pubmed/33371322
http://dx.doi.org/10.3390/antibiotics9120931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767385/
https://www.ncbi.nlm.nih.gov/pubmed/33371322
http://dx.doi.org/10.3390/antibiotics9120931

Ejemplares similares